This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A pilot study comparing the efficacy of autologous cultured fibroblast injections with hyaluronic acid fillers for treating nasolabial folds
Scientific Reports Open Access 24 April 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, C. FDA approves first cell therapy for wrinkle-free visage. Nat Biotechnol 29, 674–675 (2011). https://doi.org/10.1038/nbt0811-674
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0811-674
This article is cited by
-
A pilot study comparing the efficacy of autologous cultured fibroblast injections with hyaluronic acid fillers for treating nasolabial folds
Scientific Reports (2023)
-
Commercialization of regenerative-medicine therapies
Nature Reviews Bioengineering (2023)
-
Using New Autologous Tissue Filler Improved Nasolabial Folds−Single-Armed Pilot Study
Aesthetic Plastic Surgery (2021)
-
Biological Products: Cellular Therapy and FDA Approved Products
Stem Cell Reviews and Reports (2019)
-
Correction of Tear Trough Deformity Using Autologous Fibroblast Combined with Keratin: New Soft Tissue Filler
Aesthetic Plastic Surgery (2019)